ICD-10 Coding for Chronic Myelogenous Leukemia(C92.1, C92.10, C92.10B)
Explore ICD-10 coding for chronic myelogenous leukemia, including documentation requirements and common pitfalls.
Complete code families applicable to Chronic Myelogenous Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C92.10 | Chronic myelogenous leukemia, BCR/ABL-positive, not having achieved remission | Use when CML is active and not in remission. |
|
| C92.11 | Chronic myelogenous leukemia, BCR/ABL-positive, in remission | Use when CML is in remission, confirmed by molecular testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChronic Myelogenous Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Chronic Myelogenous Leukemia.
Failing to document remission status
Impact
Clinical: Inaccurate treatment monitoring, Regulatory: Non-compliance with coding standards, Financial: Potential for claim denials
Mitigation
Regularly update patient records with remission status, Train staff on documentation requirements
Using C92.90 for unspecified leukemia instead of specific CML codes
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Poor data quality affecting clinical outcomes tracking.
Mitigation
Use C92.1x codes with specific documentation of BCR/ABL status and remission.
Remission Documentation
Impact
Inadequate documentation of remission status can lead to audit issues.
Mitigation
Implement regular audits of patient records for remission documentation.